Sinopharm Group Co (HK:1099) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sinopharm Group Co. Ltd. has reported its unaudited interim financial results for the first half of 2024, revealing a slight decrease in gross profit and net profit compared to the same period in 2023. Despite a marginal drop in revenue, the company maintained a steady pace in its operations, with earnings per share showing a modest decline from the previous year.
For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.
